Eli Lilly and Company plans to reduce it global research and development (R&D) workforce by 200 positions as part of a voluntary reallocation program the company is offering to many of…
Teva Pharmaceutical Industries has appointed Dr. Yitzhak Peterburg as interim president and chief executive officer (CEO), effective immediately, following a mutual agreement between Teva’s board and Erez Vigodman that Mr.…
Strides Shasun to Spin Off API Business in Company Restructure
Strides Shasun, a Bangalore, India-headquartered pharmaceutical company, has announced a company restructuring that will form a consumer formulations business to be named Strides Pharma and that will include a spin-off…
Kyowa Hakko Kirin Establishes Subsidiary to Sell Amgen Biosimilar
Kyowa Hakko Kirin, a Japan-based pharmaceutical company, has established a subsidiary, Kirin Frontier Co., which will seek approval to manufacture and market a biosimilar version of Amgen’s anemia drug, Nesp (darbepoetin…
Patheon Completes Acquisition of Roche’s API Manufacturing Facility
Patheon has completed the acquisition of Roche’s active pharmaceutical ingredient (API) manufacturing facility in Florence, South Carolina, which Patheon announced in November 2016. Patheon has begun integrating the site into…
European Patent Office Decides BMS Cancer-Drug Patent is Invalid
The European Patent Office (EPO) has upheld a decision that found a patent for Bristol-Myers Squibb’s (BMS) anti-cancer drug, Sprycel (dasatinib), to be invalid. Sprycel, a leading drug in BMS’s…
Biogen Completes Spin-Off of Hemophilia Business Bioverativ
Biogen has completed the separation of its global hemophilia business into a spin-out company, Bioverativ, which now stands as an independent, publicly traded biotechnology company focused on hemophilia and other rare…
Sanofi in $61.5-Million Class-Action Settlement for Vaccine
Sanofi Pasteur, the vaccines unit of Sanofi, has agreed to pay $61.5 million to settle a class-action lawsuit involving its meningococcal vaccine, Menactra. Menactra is a key product in Sanofi’s…
Allergan, AstraZeneca, Novartis, and Teva Lead Drug Approval News
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Allergan, AstraZeneca, Novartis, and Teva. Editor’s Note: This article is updated on a continuous basis for…
Teva to Appeal Court Ruling Invalidating Patents for Top-Selling MS Drug
Teva Pharmaceutical Industries says it plans to appeal a recent court ruling that invalidated four of its patents for Copaxone (glatiramer acetate injection), a multiple sclerosis (MS) drug. Copaxone, a…